Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Johnson and Johnson
UBS
Cantor Fitzgerald
Baxter
Dow
Queensland Health
McKesson
Boehringer Ingelheim
Novartis

Generated: January 22, 2018

DrugPatentWatch Database Preview

PROCHLORPERAZINE EDISYLATE - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for prochlorperazine edisylate and what is the scope of prochlorperazine edisylate patent protection?

Prochlorperazine edisylate
is the generic ingredient in three branded drugs marketed by Glaxosmithkline, Alpharma Us Pharms, Morton Grove, Baxter Hlthcare, Athenex Inc, Emcure Pharms Ltd, Hospira, Marsam Pharms Llc, Smith And Nephew, Teva Parenteral, Watson Labs, West-ward Pharms Int, and Wyeth Ayerst, and is included in twenty NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-one drug master file entries for prochlorperazine edisylate. Four suppliers are listed for this compound.
Pharmacology for PROCHLORPERAZINE EDISYLATE
Ingredient-typePhenothiazines
Drug ClassPhenothiazine

US Patents and Regulatory Information for PROCHLORPERAZINE EDISYLATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Morton Grove PROCHLORPERAZINE EDISYLATE prochlorperazine edisylate SYRUP;ORAL 088597-001 Oct 25, 1984 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
West-ward Pharms Int PROCHLORPERAZINE EDISYLATE prochlorperazine edisylate INJECTABLE;INJECTION 089523-001 May 3, 1988 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Glaxosmithkline COMPAZINE prochlorperazine edisylate SYRUP;ORAL 011188-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Smith And Nephew PROCHLORPERAZINE EDISYLATE prochlorperazine edisylate INJECTABLE;INJECTION 089251-001 Dec 4, 1986 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Baxter Hlthcare PROCHLORPERAZINE prochlorperazine edisylate INJECTABLE;INJECTION 087759-001 Oct 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Morton Grove PROCHLORPERAZINE EDISYLATE prochlorperazine edisylate CONCENTRATE;ORAL 088598-001 Oct 25, 1984 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs PROCHLORPERAZINE EDISYLATE prochlorperazine edisylate INJECTABLE;INJECTION 089606-001 Jul 8, 1987 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Alpharma Us Pharms PROCHLORPERAZINE EDISYLATE prochlorperazine edisylate SYRUP;ORAL 087154-001 Sep 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Marsam Pharms Llc PROCHLORPERAZINE EDISYLATE prochlorperazine edisylate INJECTABLE;INJECTION 089675-001 Dec 5, 1988 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Glaxosmithkline COMPAZINE prochlorperazine edisylate INJECTABLE;INJECTION 010742-002 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Baxter
Moodys
Harvard Business School
Colorcon
Teva
Novartis
Merck
Mallinckrodt
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot